WeVote
Log In

Bill

Bill

A 1502

Provides for the restriction of substances in menstrual products

2025 Regular Session Introduced by George Alvarez and 76 co-sponsors

Bill A 1502 restricts harmful substances in menstrual products, ensuring safer options for consumers and requiring manufacturers to disclose ingredients for informed choices.

SUBSTITUTED BY S1548
0
WeVote Research Nonpartisan
Bill Summary · A 1502

Summary of Bill A 1502: Restriction of Substances in Menstrual Products

Bill Number: A 1502
Title: Provides for the restriction of substances in menstrual products
Status: Substituted by S 1548
Introduced: January 10, 2025
Classification: Bill

Purpose and Intent

Bill A 1502 aims to enhance the safety and health standards of menstrual products by restricting certain harmful substances. The intent is to ensure that products used for menstruation are free from chemicals and materials that could pose health risks to users.

Key Provisions

While the specific text of Bill A 1502 is not detailed in the provided information, the following are likely key provisions based on the bill's title and intent:

  • Substance Restrictions: The bill would establish a list of substances that are prohibited in menstrual products, which may include certain chemicals known to cause irritation, allergic reactions, or long-term health issues.

  • Labeling Requirements: Manufacturers may be required to disclose the ingredients used in menstrual products, allowing consumers to make informed choices about the products they use.

  • Compliance Timeline: The bill may outline a timeline for manufacturers to comply with the new restrictions, ensuring a gradual transition to safer products.

Affected Parties

  • Consumers: Individuals who use menstrual products would benefit from increased safety and transparency regarding the materials used in these products.

  • Manufacturers: Companies producing menstrual products would need to adjust their formulations and labeling practices to comply with the new regulations.

  • Health Organizations: Public health entities may see a reduction in health issues related to the use of unsafe menstrual products, potentially leading to improved overall health outcomes for menstruators.

Legislative Process and Timeline

  • Introduced: January 10, 2025, and referred to the Health Committee for review.

  • Reported: The bill was reported out of committee on February 4, 2025.

  • Advanced to Third Reading: The bill was advanced to the third reading on February 6, 2025, indicating it was ready for further debate and potential voting.

  • Substituted: On February 10, 2025, Bill A 1502 was substituted by S 1548, which likely contains similar provisions or further developments regarding the regulation of menstrual products.

Related Bills

  • A 8529: A prior-session bill that may have addressed similar issues.
  • A 2246: Another prior-session bill potentially related to menstrual health.
  • A 5990: A prior-session bill that could have implications for health regulations.
  • S 1548: The companion bill that has substituted A 1502, likely continuing the legislative intent of restricting harmful substances in menstrual products.

This summary provides an overview of Bill A 1502, highlighting its purpose, key provisions, affected parties, and legislative progress. The substitution by S 1548 indicates ongoing legislative efforts to improve the safety of menstrual products.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.